XML 85 R76.htm IDEA: XBRL DOCUMENT v3.24.3
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,554,658   $ 2,554,658   $ 2,137,526
Total assets 5,443,342   5,443,342   4,804,061
Current liabilities 1,649,554   1,649,554   1,410,884
Total liabilities 3,028,911   3,028,911   2,427,346
Total joint venture equity 2,312,452   2,312,452   2,287,211
Revenue 1,810,116 $ 1,418,571 5,016,259 $ 3,948,523  
Costs 1,449,831 1,124,305 3,979,589 3,109,713  
Net (loss) income attributable to Parsons Corporation 71,951 47,447 33,768 116,241  
Net income attributable to noncontrolling interests 13,638 12,364 40,428 33,617  
Consolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 503,099   503,099   426,633
Noncurrent assets 10,894   10,894   14,295
Total assets 513,993   513,993   440,928
Current liabilities 307,612   307,612   260,286
Noncurrent liabilities 2,916   2,916   5,132
Total liabilities 310,528   310,528   265,418
Total joint venture equity 203,465   203,465   $ 175,510
Revenue 193,461 185,602 582,209 514,339  
Costs 165,873 160,423 500,308 445,829  
Net (loss) income attributable to Parsons Corporation 27,588 25,179 81,901 68,510  
Net income attributable to noncontrolling interests $ 13,638 $ 12,364 $ 40,428 $ 33,617